A Few Words About Us

RDS is a nuclear technology solutions company specializing in the decontamination of radioactive surfaces. We provide engineering clean-up services based on our proprietary radionuclide ion-specific decontamination solutions.

RDS solves radiological decontamination problems through the use of our proprietary solutions. They remove radioactive contamination to acceptable levels within minutes. The solutions are water based and work by dislocating radioactive ions enabling them to be easily removed. This process provides improved decontamination, lowered dose, and major cost savings.

Our patent-pending solutions are effective on Radioactive Halogens such as iodine and fluorine; Transition Metals such as cesium and cobalt; and Actinides such as uranium, plutonium, and americium. Published data (available upon request) shows remarkable decontamination results (High Decontamination Factors (100 to 500) are common).

We operate in three market segments: Nuclear Power Industry Applications, Homeland Security Applications, and Commercial Applications.

Meet our Managing Directors

Bruno J. Schmidt, B.S., M.B.A.
Mr. Schmidt is President and Managing Director of Radiation Decontamination Solutions, LLC in Tampa, Florida. He has over 25 years experience in management, mechanical engineering, operations, consulting, manufacturing, process engineering, quality assurance, and production. His M.B.A. is in Operations Management and was awarded by Nova University in 1976. He also obtained a B.S. in Aircraft Maintenance Engineering Technology from Embry-Riddle Aeronautical University in Daytona Beach, Florida. He holds eleven patents for medical devices.

John H. Kuperus, Ph.D., R.Ph., BCNP, N. Ph.
Dr. Kuperus is a radiochemist residing in Tampa, Florida. He directs all Research and Development efforts for the company. He has developed products and filed three patents in his field. Dr. Kuperus holds a Ph.D. in Applied Sciences and Nuclear Chemistry from Pacific Western University, an M.S. in Radiopharmacy from the University of Southern California School of Pharmacy, and a B.S. in Pharmacy from the University of the Pacific. He is a registered nuclear pharmacist in Florida and California.

Kuperus has 32 years experience as a radiochemist, pharmaceutical services manager, staff nuclear pharmacist, and radiologic pharmacy coordinator. He was the Principal Investigator for a Squibb Pharmaceuticals grant. Kuperus has taught extensively at universities and published 41 studies and articles and 10 abstracts in scholarly journals. He has been an invited lecturer in the U.S. and abroad.